Clinical Strategies for the Blockade of IL-18 in Inflammatory Bowel Diseases

E-ISSN： 1873-5592|14|12|1392-1399

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.12, 2013-11, pp. : 1392-1399

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases

Current Pharmaceutical Design, Vol. 16, Iss. 33, 2010-11 ,pp. : 3656-3660

Bentham Science Publishers

Access to resources Recommend Favorite

Complementary Therapies in Inflammatory Bowel Diseases

Current Drug Targets, Vol. 15, Iss. 11, 2014-10 ,pp. : 1079-1088

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1508-1521

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention and Therapeutic Strategies of Thromboembolic Events in Patients with Inflammatory Bowel Diseases: A Report of Three Cases

Current Drug Targets, Vol. 16, Iss. 3, 2015-03 ,pp. : 194-198

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases

By Park Sang Hyoung Yang Suk-Kyun Lim Young-Suk Shim Ju Hyun Yang Dong-Hoon Jung Kee Wook Kim Kyung-Jo Ye Byong Duk Byeon Jeong-Sik Myung Seung-Jae Kim Jin-Ho

Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. : 2004-2010

Blackwell Publishing

Access to resources Recommend Favorite